Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Mol Cell Endocrinol ; 382(1): 262-270, 2014 Jan 25.
Article in English | MEDLINE | ID: mdl-24145125

ABSTRACT

Glucose-sensing neurons play a role in energy homeostasis, yet how orexigenic neurons sense glucose remains unclear. As models of glucose-inhibited (GI) neurons, mHypoE-29/1 and mHypoA-NPY/GFP cells express the essential orexigenic neuropeptide AgRP and glucose sensing machinery. Exposure to increasing concentrations of glucose or the glucose analog 2-deoxyglucose (2-DG) results in a decrease in AgRP mRNA levels. Taste receptor, Tas1R2 mRNA expression was reduced by glucose, whereas 2-DG reduced Tas1R3 mRNA levels. Increasing glucose concentrations elicited a rise in Akt and neuronal nitric oxide synthase (nNOS) phosphorylation, CaMKKß levels, and a reduction of AMP-kinase alpha phosphorylation. Inhibitors of NOS and the cystic fibrosis transmembrane conductance regulator (CFTR) prevented a decrease in AgRP secretion with glucose, suggesting a pivotal role for nNOS and the CFTR in glucose-sensing. These models possess the hallmark characteristics of GI neurons, and can be used to disentangle the mechanisms by which orexigenic neurons sense glucose.


Subject(s)
Agouti-Related Protein/biosynthesis , Agouti-Related Protein/metabolism , Glucose/pharmacology , Hypothalamus/cytology , Hypothalamus/metabolism , Models, Biological , Adenylate Kinase/metabolism , Agouti-Related Protein/genetics , Animals , Calcium-Calmodulin-Dependent Protein Kinase Kinase/metabolism , Carnitine O-Palmitoyltransferase/genetics , Carnitine O-Palmitoyltransferase/metabolism , Cell Line , Cystic Fibrosis Transmembrane Conductance Regulator/metabolism , Deoxyglucose/pharmacology , Down-Regulation/drug effects , Down-Regulation/genetics , Gemfibrozil/pharmacology , Green Fluorescent Proteins/metabolism , Hypothalamus/drug effects , Hypothalamus/embryology , Mice , Neurons/drug effects , Neurons/metabolism , Neuropeptide Y , Nitric Oxide Synthase Type I/metabolism , Phosphorylation/drug effects , Proto-Oncogene Proteins c-akt/metabolism , Pyruvic Acid/pharmacology , RNA, Messenger/genetics , RNA, Messenger/metabolism , Receptors, G-Protein-Coupled/genetics , Receptors, G-Protein-Coupled/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...